Home › Diffuse Large B-Cell Lymphoma › Iowa › Des Moines
Diffuse Large B-Cell Lymphoma clinical trials in Des Moines, IA
5 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
RecruitingPhase 2
- Research Site, Des Moines
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RecruitingPhase 2
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- and 4 more
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RecruitingPhase 2
- Mission Blood & Cancer Care ( Site 0114), Waukee · 14 mi away
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RecruitingPhase 2
- Mission Blood and Cancer - MercyOne Cancer Center, Waukee · 14 mi away
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RecruitingPhase 2
- Mercy Medical Center - Des Moines, Des Moines
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Durham, NC14 studies
- Nashville, TN14 studies
- Dallas, TX13 studies
Other studies in Des Moines
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Breast Cancer8 studies
- Chronic Lymphocytic Leukemia8 studies
- Colorectal Cancer7 studies
- Bladder Cancer6 studies
- Overweight6 studies
- Prostate Cancer5 studies
- Melanoma5 studies
- Obesity5 studies
- Multiple Myeloma5 studies
- Cardiovascular Disease5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.